Dr. Philip Louis Marjon, MD

Dr. Marjon practices at Ccare in Nashville, Tennessee.

Dr. Marjon's NPI, 1912234121, was assigned on November 9, 2009. Dr. Marjon graduated from The University of New Mexico School of Medicine in 2007. Dr. Marjon's California license number on file is C175032.

Dr. Marjon's primary practice is Ccare, at 104 Woodmont Blvd, Nashville, TN 37205 in Davidson County. The practice phone is (559) 326-1222.

Dr. Marjon's primary practice is Ccare in Nashville, Tennessee. Dr. Marjon is also affiliated with Scripps Memorial Hospital Encinitas. The medical group on file is California Cancer Associates for Research and Excellence (cCARE). Dmand AI also links Dr. Marjon to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marjon practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Marjon's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Marjon is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Marjon's licenses on file in 4 states: California, Massachusetts, Rhode Island and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Marjon treats.

CMS data shows 44,689 Medicare services from Dr. Marjon across 37 procedure codes in 2024, for 447 Medicare patients. Medicare paid $757,358 for them. Every service was in an office.

CMS counts 447 Medicare patients who saw Dr. Marjon in 2024. The largest group is 75 to 84, with 184 patients. 74% of them have high blood pressure, and 73% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marjon's median patient age at 70, with 54% women.

In 2024, Dr. Marjon wrote 531 Medicare Part D claims for 200 patients. 75% of them were for generic drugs. CMS names the drug for 300 of them, across 12 drugs with 11 or more claims each, at $491,975 in total drug cost. In 2023, CMS named 718 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Marjon for performance year 2024, reported as part of a group. Dr. Marjon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marjon as offering telehealth.

Dmand AI links 4 papers to Dr. Marjon, published from 2004 to 2014. The most frequent topics are Amino Acids, Cell Hypoxia and Endoplasmic Reticulum. Dr. Marjon's most frequent co-authors are Christine R. Bryke, MD, Vincent Falanga, MD and Sadiya S. Khan, MD.

CMS Open Payments shows 861 general payments to Dr. Marjon from 88 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,611.

Dmand AI lists 1 award for Dr. Marjon, most recently CMS Stage 1 EHR in 2013.

Dr. Marjon graduated from The University of New Mexico School of Medicine in 2007.

Dr. Marjon is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.